(Q33446629)

English

A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma

scientific article

Statements

A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit